Spyglass Pharma target price raised to $44 from $39 by Raymond James
SGP•Raymond James raised its target price for Spyglass Pharma to $44 from $39.
Related News
U.S. research roundup: Capricor Therapeutics, Charles River Laboratories, General Mills
CAPR•
Cellebrite Q3 net income rises 32% to $26.66 million
CLBT•
Dollar drops slightly from 19-month highs as rate divergence remains in focus
TLT•
Restaurant operator Arcos Dorados Q3 revenue beats estimates on higher traffic, average spend
ARCO•
Harrow plans to attend Craig-Hallum and Jefferies investor conferences
HROW•